Svetlana Mojsov, Joel Habener and Dan Drucker of Massachusetts General Hospital and Jens Juul Holst of the University of Copenhagen (left to right) provided an early understanding of the structure and function of GLP-1.
GLP-1s help many people safely manage obesity. Some new clinical studies suggest they may also reduce the risk of cardiovascular disease and even be used to help people quit smoking and drinking.